Group One Trading, L.P. Precipio, Inc. Transaction History

Group One Trading, L.P.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$0.6 - $1.0 $869 - $1,449	-1,449 Reduced 93.54%	100 $0
Q4 2022 Feb 09, 2023	SELL	$0.5 - $17.4 $7,434 - $258,703	-14,868 Reduced 90.56%	1,549 $0
Q3 2022 Nov 09, 2022	SELL	$0.78 - $17.8 $78 - $1,780	-100 Reduced 0.61%	16,417 $13,000
Q2 2022 Aug 11, 2022	BUY	$0.98 - $1.68 $65 - $112	67 Added 0.41%	16,517 $18,000
Q1 2022 May 12, 2022	SELL	$1.19 - $1.71 $5,030 - $7,228	-4,227 Reduced 20.44%	16,450 $22,000
Q4 2021 Feb 11, 2022	BUY	$1.58 - $2.77 $6,004 - $10,526	3,800 Added 22.52%	20,677 $33,000
Q3 2021 Nov 12, 2021	BUY	$2.78 - $3.63 $41,358 - $54,003	14,877 Added 743.85%	16,877 $48,000
Q2 2021 Aug 10, 2021	BUY	$1.8 - $5.25 $3,600 - $10,500	2,000 New	2,000 $7,000

340

Ticker PRPO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 22,736,500
Market Cap $134M
Description
Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScreen, a suite of robust geneti...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.